摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-(piperidin-1-yl)-2-p-tolylacetate | 1142290-51-4

中文名称
——
中文别名
——
英文名称
methyl 2-(piperidin-1-yl)-2-p-tolylacetate
英文别名
methyl 2-(4-methylphenyl)-2-piperidin-1-ylacetate
methyl 2-(piperidin-1-yl)-2-p-tolylacetate化学式
CAS
1142290-51-4
化学式
C15H21NO2
mdl
——
分子量
247.337
InChiKey
INJLQCDTRUQNEV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    methyl 2-(piperidin-1-yl)-2-p-tolylacetate盐酸 作用下, 以 1,4-二氧六环 为溶剂, 反应 4.0h, 以81%的产率得到2-(piperidin-1-yl)-2-p-tolylacetic acid hydrochloride
    参考文献:
    名称:
    QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF
    摘要:
    式(I)化合物: 其中A、R1、R2、X、m和n如说明书中所定义,是选择性的M3受体拮抗剂,可用于治疗,包括但不限于,呼吸系统疾病,如哮喘和慢性阻塞性肺病(COPD)。
    公开号:
    US20130172302A1
  • 作为产物:
    描述:
    哌啶2,2'-联吡啶N-溴代丁二酰亚胺(NBS) 、 copper(I) bromide 作用下, 以 1,2-二氯乙烷 为溶剂, 反应 5.0h, 生成 methyl 2-(piperidin-1-yl)-2-p-tolylacetate
    参考文献:
    名称:
    Copper(I)-catalyzed coupling reaction of aryl boronic acids with N,O-acetals and N,N-aminals under atmosphere leading to α-aryl glycine derivatives and diarylmethylamine derivatives
    摘要:
    We demonstrated a copper(I)-catalyzed coupling reaction of aryl boronic acids with N,O-acetals and N,N-aminals leading to the synthesis of alpha-aryl glycines and diarylmethylamines. Under an ambient atmosphere, this catalytic system could be applied to the activation of a C(sp(3))-O bond of N,O-acetals with an ester and an aryl group, or without a coordinating substituent, as well as to a C(sp(3))-N bond of N,N-aminals. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2015.05.068
点击查看最新优质反应信息

文献信息

  • [EN] QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF<br/>[FR] ESTERS DE QUINUCLIDINE ET D'ACIDE 1-AZAHÉTÉROCYCLYLACÉTIQUE UTILISÉS COMME AGENTS ANTIMUSCARINIQUES, PROCÉDÉ POUR LEUR PRÉPARATION ET COMPOSITIONS MÉDICINALES CORRESPONDANTES
    申请人:CHIESI FARMA SPA
    公开号:WO2013098145A1
    公开(公告)日:2013-07-04
    The invention relates to compounds of formula (I), wherein A, R1, R2, X, m and n are as defined in the specification, as selective M3 receptor antagonists, process for their preparation, composition comprising them and the therapeutic use thereof. Said compounds may be used in the treatment of, inter alia, a respiratory disease such as asthma and COPD.
    本发明涉及通式(I)的化合物,其中A、R1、R2、X、m和n如说明书中所定义,作为选择性M3受体拮抗剂,其制备方法,包含它们的组合物及其治疗用途。这些化合物可用于治疗,特别是呼吸系统疾病,如哮喘和慢性阻塞性肺病(COPD)。
  • Bulk Gold-Catalyzed Reactions of Diazoalkanes with Amines and O2 to Give Enamines
    作者:Yibo Zhou、Robert J. Angelici、L. Keith Woo
    DOI:10.1007/s10562-010-0339-7
    日期:2010.6
    particles, catalyzes reactions of diazoalkanes E(H)C=N2, where E is CO2Et or PhC(O), with amines R1R2NH and O2 to give enamine products (R1R2N)(E)C=CH(E) in 58–94% yield. The reactions are proposed to occur by initial formation of surface-bound (E)(H)C: carbene groups that are attacked by nucleophilic amines. The enamine products are very different than those obtained in reactions catalyzed by homogeneous
    散装粉,由大约 5-50 μm 的颗粒组成,催化重氮烷烃 E(H)C=N2,其中 E 是 CO2Et 或 PhC(O),与胺 R1R2NH 和 O2 反应生成烯胺产物 (R1R2N)(E) C=CH(E),产率为 58-94%。这些反应被认为是通过最初形成表面结合的 (E)(H)C:被亲核胺攻击的卡宾基团而发生的。烯胺产物与由均相过渡属配合物催化的反应中获得的产物有很大不同。重氮烷、胺和 O2 的这些反应代表了一种新型的本体催化反应。
  • Facile Approach to Natural or Non-Natural Amino Acid Derivatives: Me<sub>3</sub>SiCl-Promoted Coupling Reaction of Organozinc Compounds with N,O-Acetals
    作者:Norio Sakai、Junichi Asano、Yuki Kawada、Takeo Konakahara
    DOI:10.1002/ejoc.200801107
    日期:2009.2
    We have developed a Me3SiCl-promoted coupling reaction of aryl- and alkylzinc compounds, in-situ generated either by transmetalation of the corresponding organometallic reagents or by insertion of zinc metal into organic halides, with several N,O-acetals, which leads to the preparation of a variety of natural and non-natural amino acid derivatives. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim
    我们开发了一种 Me3SiCl 促进的芳基和烷基化合物的偶联反应,通过相应的有机属试剂的属转移或通过将属插入有机卤化物中而原位生成,与几种 N,O-缩醛,这导致制备多种天然和非天然氨基酸生物。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)
  • Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof
    申请人:Chiesi Farmaceutici S.p.A.
    公开号:US08748613B2
    公开(公告)日:2014-06-10
    Compounds of formula (I): wherein A, R1, R2, X, m, and n are as defined in the specification, are selective M3 receptor antagonists and may be used in the treatment of, inter alia, a respiratory disease such as asthma and COPD.
    式(I)的化合物:其中A,R1,R2,X,m和n如规范所定义,是选择性M3受体拮抗剂,可用于治疗呼吸系统疾病,例如哮喘和慢性阻塞性肺疾病(COPD)。
  • A copper(<scp>ii</scp>) bromide/NMO system for α-amination of esters under continuous-flow conditions with reduced catalyst loading
    作者:Yaman Chauhan、Kankanala Naveen Kumar、V. Ravichandiran、Sonali Bindita Jethy、Nirmala Mohanta、Sharada Prasanna Swain
    DOI:10.1039/d3nj05456j
    日期:——
    A new copper(II) bromide/N-methylmorpholine N-oxide (NMO)-promoted method for α-amination of esters under continuous-flow conditions, with reduced catalyst loading is reported. The α-amino esters are precursors for the synthesis of α-amino acids. This method provides α-amino esters in 58–83% yields. The desired Cu(II)Br catalyst is regenerated by in situ oxidation of Cu(I)Br in the presence of NMO
    报道了一种新的溴化铜( II )/ N-甲基吗啉N-氧化物(NMO)促进的连续流动条件下酯的α-胺化方法,并减少了催化剂负载量。α-基酯是合成α-氨基酸的前体。该方法提供 α-基酯,产率为 58-83%。所需的 Cu( II )Br 催化剂通过在 NMO 存在下原位氧化 Cu( I )Br来再生。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸